MHRA Drug Safety Update – April 2018

MHRA Drug Safety Update – April 2018

April 24, 2018

Date issued: 24th April 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 9, April 2018) has been published and includes articles on:

  • valproate medicines (Epilim▼, Depakote▼): contraindicated in women and girls of childbearing potential unless conditions of Pregnancy Prevention Programme are met;
  • obeticholic acid (Ocaliva▼): risk of serious liver injury in patients with pre-existing moderate or severe hepatic impairment; reminder to adjust dosing according to liver function monitoring; and
  • suspect an adverse reaction? Yellow Card it!

To see the latest MHRA Drug Safety Update in full, visit the GOV.UK website.



Posted in:


More Latest News >

PSNC updates its Privacy Notice

The General Data Protection Regulation (GDPR) and relevant provisions of domestic law – i.e. the UK Data Protection Act 2018...

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...